Cadila Healthcare may gain after getting USFDA approval for drug

Cadila Healthcare announced that it has received the tentative approval from the United States Food and Drug Administration (USFDA) to market Fingolimod Capsules, 0.5 mg. The drug is an immunomodulating drug, mostly used for treating multiple sclerosis and will be produced at the group's formulations manufacturing facility at the Pharma SEZ, in Ahmedabad. The sales of Fingolimod Capsules is estimated at $2.1 billion as per IMS Health data. The announcement was made after market hours on Friday, 14 July 2017.

The group now has more than 120 approvals and has so far filed over 300 abbreviated new drug applications (ANDAs) since the commencement of the filing process in FY 2003-04.

Among prominent companies, ACC and Jubilant FoodWorks will announce April-June 2017 results today, 17 July 2017.

Sunteck Realty announced that it has fixed 26 July 2017 as the record date for 2-for-1 stock split. The announcement was made after market hours on Friday, 14 July 2017.

Suzlon Energy announced on Saturday, 15 July 2017, the filing of voluntary liquidation of its Brazilian subsidiary Suzlon Energia Eolica do Brasil Ltda (SEOB). SEOB was established to manage business opportunities in Brazil in 2006. SEOB has taken this decision after carefully considering all options and as a consequence of multiple factors that are unique to Brazil, Suzlon said. The decision does not, in any way, alter Suzlon's global operations strategy, it added.

DCB Bank's net profit rose 39% to Rs 65 crore on 34% rise in total income to Rs 319 crore in Q1 June 2017 over Q1 June 2016. The announcement was made on Saturday, 15 July 2017.

Karnataka Bank's net profit rose 10.13% to Rs 133.85 crore on 7.87% rise in total income to Rs 1547.94 crore in Q1 June 2017 over Q1 June 2016. The announcement was made on Saturday, 15 July 2017.

Gruh Finance's net profit rose 20% to Rs 72.24 crore on 15% rise in total income to Rs 398.12 crore in Q1 June 2017 over Q1 June 2016. The announcement was made on Saturday, 15 July 2017.

TCPL Packaging said that board of directors of the company approved issue, offer and allotment of 4 lakh equity shares of the company at a price of Rs 600 per share on a preferential basis through private placement, for a total consideration of Rs 24 crore. The announcement was made on Saturday, 15 July 2017.

Alkem Laboratories said that USFDA had conducted an inspection at the company's Bioequivalence facility located at Taloja, India from 10th July, 2017 to 14th July, 2017. At the end of the inspection, no Form 483 was issued. The announcement was made after market hours on Friday, 14 July 2017.

Powered by Capital Market - Live News